The NET Alliance™ and Novartis Oncology continue their commitment to improving knowledge and management of neuroendocrine tumors, and empowering patients to be more informed advocates.

  • А
  • А
  • А

Common gastrointestinal symptoms could indicate a neuroendocrine tumor

At least 13 types of neuroendocrine cells exist in the gastrointestinal (GI) tract, all of which secrete bioactive peptides or amines.2

Neuroendocrine tumors (NET) can arise from these cells in the small intestine and proximal colon and exhibit secretory activity.3

NET arising in the distal colon and rectum, conversely, are usually nonfunctional and cause symptoms owing to increasing tumor mass.2-4

All of these GI NET can produce nonspecific symptoms that are uncomfortable for patients and challenging for physicians.3

The clues to carcinoid syndrome

Carcinoid syndrome is one of the more common clinical manifestations of NET, occurring in 8% to 35% of patients.5

Carcinoid, or functional, syndrome occurs most frequently when certain types of GI NET metastasize to the liver, which allows secreted serotonin and other vasoactive substances to bypass hepatic metabolism and directly enter systemic circulation.2,5 Other substances include corticotropin, histamine, dopamine, substance P, neurotensin, prostaglandins, kallikrein, and tachykinins.4

Oversecretion of these substances can cause the cluster of symptoms known as carcinoid syndrome. These include flushing, diarrhea, cramping, and wheezing.6 Additionally, cardiac disease is one of the most serious aspects of carcinoid syndrome, occurring in approximately two-thirds of patients.7

Because these symptoms are nonspecific, they are often attributed to other more common conditions, such as irritable bowel syndrome. However, by distinguishing certain clues, physicians can make a differential diagnosis to rule out or preliminarily identify a GI NET as a possible cause.3,9

Patients may be more likely to have cardiac disease when they exhibit 5-HIAA levels ≥300 µmol (57 mg) over 24 hours and flushing episodes ≥3 per day.8

Other types of GI NET

GI NET may be associated with other symptoms and syndromes, depending on the tumor’s site of origin. Click on the figure to learn more.

Chart showing the Classification of Neuroendocrine Tumors (NET)

Resource for Nurses: Take the NET Nurse Quiz! 

The NET Nurse Quiz is an interactive quiz to test your knowledge on neuroendocrine tumors and how the disease affects your patients.

Are you ready for the quiz?